Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Operating Expenses (2020 - 2023)

Historic Other Operating Expenses for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $13.9 million.

  • ADC Therapeutics' Other Operating Expenses rose 17682.73% to $13.9 million in Q3 2023 from the same period last year, while for Dec 2023 it was $3.7 billion, marking a year-over-year decrease of 1885.85%. This contributed to the annual value of $4.8 billion for FY2022, which is N/A changed from last year.
  • ADC Therapeutics' Other Operating Expenses amounted to $13.9 million in Q3 2023, which was up 17682.73% from $15.6 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Other Operating Expenses ranged from a high of $4.6 billion in Q2 2022 and a low of -$73.4 million during Q1 2020
  • In the last 4 years, ADC Therapeutics' Other Operating Expenses had a median value of -$16665.0 in 2022 and averaged $642.9 million.
  • Per our database at Business Quant, ADC Therapeutics' Other Operating Expenses tumbled by 13397.6% in 2022 and then surged by 1971809.09% in 2023.
  • Over the past 4 years, ADC Therapeutics' Other Operating Expenses (Quarter) stood at -$6.1 million in 2020, then soared by 973.06% to $53.4 million in 2021, then crashed by 100.03% to -$16665.0 in 2022, then surged by 83736.36% to $13.9 million in 2023.
  • Its last three reported values are $13.9 million in Q3 2023, $15.6 million for Q2 2023, and $3.7 billion during Q1 2023.